XML 128 R85.htm IDEA: XBRL DOCUMENT v3.21.4
Condensed Financial Information of the Parent Company -Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities          
Net income (loss) $ 2,356,438 $ 813,455 $ (311,004)    
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:          
Amortization of deferred financing costs   1,093,440 2,113,492    
Accrued interest expense for convertible notes   135,867 1,087,774    
Share-based compensation 1,260,674        
Other current assets (258,117) 54,749 (51,300)    
Other current liabilities (559,915) (172,089) 605,480    
Net cash used in operating activities (52,907,013) (1,616,423) (10,773,287)    
Cash flows from investing activities          
Net cash used in investing activities (12,258,220) (247,240) (94,905)    
Cash flows from financing activities          
Net proceeds from stock issuance 126,010,538        
Payments of deferred financing costs     (716,318)    
Gross proceeds from issuance of convertible note     7,500,000    
Repayment of advances from related parties 2,147,199 938,071 87,800    
Net cash provided by financing activities 122,412,800 3,201,645 6,056,040    
Net increase (decrease) in cash and restricted cash 57,097,363 1,411,336 (4,771,350)    
Cash and restricted cash from continuing operations 2,165,151 753,815 5,525,165    
Cash and restricted cash, end of year 59,262,514 2,165,151 753,815 $ 5,525,165  
FAMI | Reportable legal entity          
Cash flows from operating activities          
Net income (loss) 2,358,414 823,606 (307,437)    
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:          
Amortization of deferred financing costs   1,093,440 2,113,492    
Equity in earnings of subsidiary (4,395,592) (2,656,075) (3,514,062)    
Accrued interest expense for convertible notes   135,867 1,087,774    
Share-based compensation 1,260,674        
Other current assets (125,081)        
Other current liabilities (40,000) 40,000 (47,224)    
Net cash used in operating activities (941,585) (563,162) (667,457)    
Cash flows from investing activities          
Investing in subsidiaries (122,726,999) 688,060 (5,999,297)    
Net cash used in investing activities (122,726,999) 688,060 (5,999,297)    
Cash flows from financing activities          
Net proceeds from stock issuance 126,029,588        
Payments of deferred financing costs     (716,318)    
Gross proceeds from issuance of convertible note     7,500,000    
Proceeds from advances from related parties 298,297        
Repayment of advances from related parties (2,138,508) (758,071) (87,800)    
Net cash provided by financing activities   124,189,377   (758,071) $ 6,695,882
Net increase (decrease) in cash and restricted cash 520,793 (633,173) 29,128    
Cash and restricted cash from continuing operations 2,122 635,295 606,167    
Cash and restricted cash, end of year $ 522,915 $ 2,122 $ 635,295 $ 606,167